Market Overview:
The global bacterial vaccines market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing incidence of infectious diseases, rising demand for preventive healthcare, and technological advancements in vaccine development. Based on type, the global bacterial vaccines market is segmented into capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, killed bacterial vaccines and others. Capsular polysaccharide vaccine dominates this market due to their high efficacy against various types of bacteria and growing demand for them in developed countries. However, live attenuated bacterial vaccine segment is expected to grow at a higher CAGR during the forecast period owing to their advantages over other types of bacteria vaccinations such as ease of administration and better safety profile. Based on application, the global bacterial Vaccines Market is segmented into hospital pharmacies; retail pharmacies; online pharmacies; government organizations & public health institutes; research laboratories & academic institutes; contract manufacturing organizations (CMOs) and others including veterinary clinics & farms).
Product Definition:
A bacterial vaccine is a vaccine that uses bacteria to help the body build immunity to specific diseases. Bacterial vaccines are used to prevent or treat infections caused by bacteria.
Capsular Polysaccharide Vaccines:
Capsular polysaccharide vaccines (CPSV) are a new type of vaccine that is being extensively studied for its potential to induce strong protective immune responses against bacterial infections. The mechanism by which they work remains unclear, but it is presumed to be related to the ability of the product to trigger an adaptive immune response in target cells.
The first clinical trial using CPSV as a bacterial vaccine was published in 2012; since then numerous research groups have been conducting trials with different types.
Toxoid Vaccines:
Toxoid vaccines are made from bacterial toxins and are used in bacterial vaccines. Toxoid vaccine consists of a protein coat which is composed of an outer membrane covering the antigen, this protects the antigen from being destroyed by antibodies. The most commonly used toxoids are those for diphtheria, tetanus, and pertussis (whooping cough).
The advantages associated with these vaccines include it's ability to stimulate cellular immune response without causing serious side effects.
Application Insights:
The hospital pharmacies segment held the largest share of 60.0% in 2017. This is attributed to factors such as presence of a large patient base with chronic diseases and high usage rates of antibiotics among patients. Furthermore, increasing investments by government bodies to improve healthcare infrastructure and facilities are expected to boost market growth over the forecast period.
The retail pharmacies segment is anticipated to witness lucrative growth during the forecast period owing to rising awareness regarding preventable diseases along with an increase in spending capacity among consumers, especially in emerging economies such as China and India. Moreover, growing demand for vaccines due to rapid urbanization along with a rise in disposable income will fuel industry expansion over the coming years (Ref).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as rising incidence of bacterial infections, increasing prevalence of chronic diseases, and growing demand for improved healthcare facilities. Moreover, high adoption rate of new technologies and a large number of manufacturers in this region are also expected to drive the market during the forecast period. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure coupled with rising awareness regarding vaccination programs among people living in rural areas as well as urban centers.
Moreover, an increase in travel activities has led authorities concerned with disease control & prevention efforts towards ensuring that all travelers from countries where these vaccines are not recommended or used against have immunity against these diseases before traveling overseas thus creating demand for bacterial vaccines globally (Gould et al., 2016).
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the bacterial vaccines market. Infectious diseases are caused by pathogenic microorganisms, which can spread from one person to another and cause serious health problems. The growing awareness about the prevention and treatment of infectious diseases is expected to drive the demand for bacterial vaccines in the coming years.
- Technological advancements in vaccine development: The technological advancements in vaccine development are another key factor driving the growth of the bacterial vaccines market. With continuous research and development activities, new and innovative bacterial vaccines are being developed that offer better protection against various infections. This is expected to boost demand for these products in the coming years.
- Growing public-private partnerships: There has been a significant increase in public-private partnerships over recent years aimed at developing novel bacterial vaccines products faster than ever before possible with traditional pharmaceutical industry investment models alone could achieve it .This trend is likely to continue owing to increased funding opportunities from both government agencies as well as private investors interested specifically microbial threats such as pandemics or bioterrorism agents .Thus this will spur innovation within this sector with consequent benefits translating into more efficacious prophylactic regimens available on a wider scale including developing countries who have hitherto had little access to modern medical technologies let alone cutting edge vaccinology interventions .
Scope Of The Report
Report Attributes
Report Details
Report Title
Bacterial Vaccines Market Research Report
By Type
Capsular Polysaccharide Vaccines, Toxoid Vaccines, Purified Protein Vaccines, Live Attenuated Bacterial Vaccines, Killed Bacterial Vaccines, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Pfizer, Merck, GlaxoSmithKline, Sanofi, PaxVax, Serum Institute of India, Emergent BioDefense Operations Lansing
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
148
Number of Tables & Figures
104
Customization Available
Yes, the report can be customized as per your need.
Global Bacterial Vaccines Market Report Segments:
The global Bacterial Vaccines market is segmented on the basis of:
Types
Capsular Polysaccharide Vaccines, Toxoid Vaccines, Purified Protein Vaccines, Live Attenuated Bacterial Vaccines, Killed Bacterial Vaccines, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Merck
- GlaxoSmithKline
- Sanofi
- PaxVax
- Serum Institute of India
- Emergent BioDefense Operations Lansing
Highlights of The Bacterial Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Capsular Polysaccharide Vaccines
- Toxoid Vaccines
- Purified Protein Vaccines
- Live Attenuated Bacterial Vaccines
- Killed Bacterial Vaccines
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bacterial Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bacterial vaccines are vaccines that use live bacteria to help the body build immunity against certain diseases.
Some of the major companies in the bacterial vaccines market are Pfizer, Merck, GlaxoSmithKline, Sanofi, PaxVax, Serum Institute of India, Emergent BioDefense Operations Lansing.
The bacterial vaccines market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bacterial Vaccines Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bacterial Vaccines Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bacterial Vaccines Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bacterial Vaccines Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bacterial Vaccines Market Size & Forecast, 2020-2028
4.5.1 Bacterial Vaccines Market Size and Y-o-Y Growth
4.5.2 Bacterial Vaccines Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Capsular Polysaccharide Vaccines
5.2.2 Toxoid Vaccines
5.2.3 Purified Protein Vaccines
5.2.4 Live Attenuated Bacterial Vaccines
5.2.5 Killed Bacterial Vaccines
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bacterial Vaccines Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bacterial Vaccines Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Capsular Polysaccharide Vaccines
9.6.2 Toxoid Vaccines
9.6.3 Purified Protein Vaccines
9.6.4 Live Attenuated Bacterial Vaccines
9.6.5 Killed Bacterial Vaccines
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Capsular Polysaccharide Vaccines
10.6.2 Toxoid Vaccines
10.6.3 Purified Protein Vaccines
10.6.4 Live Attenuated Bacterial Vaccines
10.6.5 Killed Bacterial Vaccines
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Capsular Polysaccharide Vaccines
11.6.2 Toxoid Vaccines
11.6.3 Purified Protein Vaccines
11.6.4 Live Attenuated Bacterial Vaccines
11.6.5 Killed Bacterial Vaccines
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Capsular Polysaccharide Vaccines
12.6.2 Toxoid Vaccines
12.6.3 Purified Protein Vaccines
12.6.4 Live Attenuated Bacterial Vaccines
12.6.5 Killed Bacterial Vaccines
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Capsular Polysaccharide Vaccines
13.6.2 Toxoid Vaccines
13.6.3 Purified Protein Vaccines
13.6.4 Live Attenuated Bacterial Vaccines
13.6.5 Killed Bacterial Vaccines
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bacterial Vaccines Market: Competitive Dashboard
14.2 Global Bacterial Vaccines Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Merck
14.3.3 GlaxoSmithKline
14.3.4 Sanofi
14.3.5 PaxVax
14.3.6 Serum Institute of India
14.3.7 Emergent BioDefense Operations Lansing
